Effect of dietary, pharmacological, and genetic topoisomerase ablation on Ph-like ALL risk in Hispanics

饮食、药物和遗传拓扑异构酶消融对西班牙裔 Ph 样 ALL 风险的影响

• 批准号: 10598405
• 负责人: Nicholas Pannunzio
• 金额: $ 5.97万
• 依托单位: UNIVERSITY OF CALIFORNIA-IRVINE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-02-14 至 2027-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10598405
• 关键词: Ablation; Award; Genetic; Hispanic Populations; Instruction; Parents; Pharmacology; Research; Risk; Topoisomerase; dietary

The instructions from FOA PA-21-071 indicate that “At a minimum, the Research Strategy section should be completed and must include a summary or abstract of the parent award or project. Other sections should also be included if they are being changed by the proposed supplement activities.” The Project Summary/Abstract will not be changed as a result of the activities associated with this supplement.

FOA PA-21-071的说明指出，“至少，研究策略 部分应完成，必须包括一个总结或摘要的母裁决或 项目如果其他部分被拟议的 补充活动”。 项目摘要/摘要不会因以下活动而更改： 这个补充。